Abstract
Introduction & hypothesis
Previous studies have suggested that women with urinary incontinence have an altered urinary microbiome. We hypothesized that the microbiome in women with mixed urinary incontinence (MUI) differed from controls and tested this hypothesis using bacterial gene sequencing techniques.
Methods
This multicenter study compared the urinary microbiome in women with MUI and similarly aged controls. Catheterized urine samples were obtained; v4–6 regions of the 16S rRNA gene were sequenced to identify bacteria. Bacterial predominance (> 50% of an individual’s genera) was compared between MUI and controls. Bacterial sequences were categorized into “community types” using Dirichlet multinomial mixture (DMM) methods. Generalized linear mixed models predicted MUI/control status based on clinical characteristics and community type. Post-hoc analyses were performed in women < 51 and ≥ 51 years. Sample size estimates required 200 samples to detect a 20% difference in Lactobacillus predominance with P < 0.05.
Results
Of 212 samples, 97.6% were analyzed (123 MUI/84 controls, mean age 53 ± 11 years). Overall Lactobacillus predominance did not differ between MUI and controls (45/123 = 36.6% vs. 36/84 = 42.9%, P = 0.36). DMM analyses revealed six community types; communities differed by age (P = 0.001). A High-Lactobacillus (89.2% Lactobacillus) community had a greater proportion of controls (19/84 = 22.6%, MUI 11/123 = 8.9%). Overall, bacterial community types did not differ in MUI and controls. However, post-hoc analysis of women < 51 years found that bacterial community types distinguished MUI from controls (P = 0.041); Moderate-Lactobacillus (aOR 7.78, CI 1.85–32.62) and Mixed (aOR 7.10, CI 1.32–38.10) community types were associated with MUI. Community types did not differentiate MUI and controls in women ≥ 51 years (P = 0.94).
Conclusions
Women with MUI and controls did not differ in overall Lactobacillus predominance. In younger women, urinary bacterial community types differentiated MUI from controls.
Similar content being viewed by others
References
Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J. 2017;28:687–96.2.
Sung VW, Borello-France D, Dunivan G, et al. Methods for a multicenter randomized trial for mixed urinary incontinence: rationale and patient- centeredness of the ESTEEM trial. Int Urogynecol J. 2016;27:1479–90.
Brubaker L, Wolfe AJ. The female urinary microbiota/microbiome: clinical and research implications. Rambam Maimonides Med J 2017;8.
Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5:e01283–14.
Thomas-White KJ, Hilt EE, Fok C, et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J. 2016;27:723–33.
Komesu YM, Richter HE, Dinwiddie DL, et al. Methodology for a vaginal and urinary microbiome study in women with mixed urinary incontinence. Int Urogynecol J. 2017;28:711–20.
Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Continence program in women (CPW) research group. Qual Life Res. 1994;3:291–306.
Coyne KS, Margolis MK, Bavendam T, Roberts R, Elinoff V. Validation of a 3-item OAB awareness tool. Int J Clin Pract. 2011;65:219–24.
Sandvik H, Seim A, Vanvik A. Hunskaar S. A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests. Neurourol Urodyn. 2000;19:137–45.
Kumar PS, Brooker MR, Dowd SE, Camerlengo T. Target region selection is a critical determinant of community fingerprints generated by 16S pyrosequencing. PLoS One. 2011;6(6):e20956.
Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–7.
Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS On3. 2012;7(2):e30126.
La Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, et al. Hypothesis testing and power calculations for taxonomic-based human Mcrobiome data. PLoS One. 2012;7(12):e52708.
Brotman RM, Shardel MD, Gajer P, Fadrosh D, Change K, Silver MI, et al. Association between the vaginal microbiota, menopause status and signs of vulvovaginal atrophy. Menopause. 2013;21(5):1–9.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract—a role beyond infection. Nat. RevUrol. 2015;12:81–90.
Practice Bulletin No ACOG. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123:202–16.
Minchin PR. An evaluation of the relative robustness of techniques for ecological ordination. Vegetatio. 1987;69:89–107.
Distance-based redundancy analysis: testing multispecies responses in multifactorial ecological experiments (vol 69, pg 1, 1999). Ecol Monogr. 1999;69:512–2.
Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2006;26:32–46.
Anderson MJ. Permutation tests for univariate or multivariate analysis of variance and regression. Can J Fish Aquat Sci. 2001;58:626–39.
Curtiss N, Balachandran A, Krska L, Peppiatt-Wildman C, Wildman S, Duckett J. A case controlled study examining the bladder microbiome in women with overactive bladder (OAB) and healthy controls. Eur J Obstet Gynecol Reprod Biol. 2017;214:31–5.
Thomas-White KJ, Kliethermes S, Rickey L, et al. Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence. Am J Obstet Gynecol 2017;216:55 e1–55 e16.
Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT, et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol. 2016;6(78):1–13.
Kroke A, Schulz M, Hoffman K, Bermann MM, Boeing H. Assignment to menopausal status and estimation of age at menopause for women with missing or invalid data—a probabilistic approach with weighting factors in a large-scale epidemiologic study. Maturitas. 2001;40:39–46.
Harlow SD, Crawford SL, Sommer B, Greendale GA. Self-defined menopausal status in a multi-ethnic sample of midlife women. Maturitas. 2000;36:93–122.
Acknowledgements
The authors thank the research coordinators and all those who made this work possible, including University of Alabama at Birmingham: R. Edward Varner, MD, Robert L. Holley, MD, David R. Ellington, MD, Isuzu Meyer, MD, Alison Parden, MD, Alicia Ballard, MD, Velria Willis, BSN, Nancy Saxon, BSN, and Kathy Carter, BSN. Brown University: Deborah Myers, MD, Charles Rardin, MD, Brittany Star Hampton, MD, Cassandra Carberry, MD, Kyle Wohlrab, MD, Ann Meers, BSN, and Katheryn Rhodes, BA. Cleveland Clinic Foundation: Matthew Barber, MD, Marie Paraiso, MD, Eric Jelovsek, MD, Cecile Unger, MD, Audra Hill, MD, Ly Pung, RN, Kathleen Dastoli, RN, Annette Graham, RN, and Maryori Edington. Duke University: Cindy Amundsen, MD, Anthony Visco, MD, Alison Weidner, MD, Amie Kawasaki, MD, Shantae McLean, Nicole Longoria and Akira Hayes. University of California San Diego: Marianna Alperin, MD, Michael Albo, MD, Laura Aughinbaugh, RNP, Joann Columbo, Cindy Furey, PT, Sherella Johnson, Charles Nager, MD, and Patsy Riley, RN. Kaiser San Diego: Shawn Menefee, MD, Jasmine Tan-Kim, MD, Keisha Dyer, MD, Gouri Diwadkar, MD, Karl Luber, MD, Lynn Hall, RNP, Gisselle Zazueta-Damian and Linda MacKinnon. Kaiser Bellflower: John N. Nguyen, MD, Sharon Jakus-Walkman, MD, Azadeh Rezvan, MD, Christina Liao, MD, Arty Patel, PT, Mary Simmons, PT, Mercedes Cardona and Nancy Flores. University of New Mexico: Gena Dunivan, MD, Peter Jeppson, MD, Sara Cichowski, MD, Karen Taylor, BA, Cassandra Castaneda, BA, Julia Middendorf, BSN, Susan Tigert, BA/BS, Kurt Schwalm, BS, and Amy Overby, BS, CG/MB/PA(ASCP)CM. University of Pennsylvania: Heidi Harvie, MD, Uduak Andy, MD, Lorraine Flick and Michelle Kinglee. University of Pittsburgh: Pamela Moalli, PhD, MD, Michael Bonidie, Gary Sutkin, MD, Jonathan Shepherd, MD, Christopher Chermansky, MD, Judy Gruss, Karen Mislanovich and Lori Geraci. RTI International: Dennis Wallace, PhD, Carolyn Huitema, MS, Michael Ham, BS, and Joshua Levy, MS.
Funding source and sponsor’s role
The Eunice Kennedy Shriver National Institute of Child Health and Human Development sponsored this Pelvic Floor Disorders Network (PFDN) study (1-U10-HD069025–01, 2-U10-HD041261–11, 2-U10-HD041267–12, 1-U10-HD069013–01, 2-U10-HD054214–06, 2-U10-HD054215–06, 1-U10-HD069010–01, 1-U10-HD069006–01, 1-U01HD069031–01). ClinicalTrials.gov Number NCT01959347.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Presentation of information in this manuscript
Oral poster presented at the Pelvic Floor Disorders Week Conference (sponsored by the American Urogynecologic Society), October 5, 2017, Providence, Rhode Island; e-oral poster presented at the International Continence Society annual meeting, Florence, Italy, September 13, 2017.
Other support
National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health (grant no. ULTR001449, the University of New Mexico Clinical and Translational Science Center) (for performance of DNA extraction, 16S sequencing).
Author’s potential conflicts of interest/disclosures
Yuko Komesu, MD: Co-PI Grant 1R01AT007171, National Center Complementary and Integrative Health, NIH and “Funding Source” above. Holly Richter, PhD, MD: UpToDate, Renovia. Benjamin Carper: None.Darrell L. Dinwiddie, PhD: None. Emily S. Lukacz, MD: AMS/Astora, Axonics, Boston Scientific, Uroplasty/Coloplast, UptoDate. Nazema Y. Siddiqui, MD: Medtronic. Vivian W. Sung, MD: None. Halina M. Zyczynski, MD: AUGS Board. Beri Ridgeway, MD: Coloplast, Ethicon. Rebecca G. Rogers, MD: UptoDate, ABOG Board member, Transform Trial, International Urogynecology Journal. Lily A. Arya, MD: None. Donna Mazloomdoost, MD: None. Marie G. Gantz, PhD: None.
Rights and permissions
About this article
Cite this article
Komesu, Y.M., Richter, H.E., Carper, B. et al. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Int Urogynecol J 29, 1785–1795 (2018). https://doi.org/10.1007/s00192-018-3683-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-018-3683-6